Big data and AI meet cancer research

Many cancer patients undergo treatment with multiple drugs, each of which attacks cancer in a different way, so the combination fights cancer on many fronts. But more drugs mean higher risks of side effects. "Most cancer therapy is now a combination treatment," says Avinash (Avi) Sahu, Ph.D., assistant professor at The University of New Mexico Comprehensive Cancer Center. Sahu joined UNM from Harvard and Dana-Farber Cancer Institute. "We wanted to find drugs that could suppress two cancer-causing pathways at the same time."